15 October 2024 - Clinical-stage biopharmaceutical company Saniona (STO:SANION) announced on Tuesday that its collaboration with Boehringer Ingelheim has advanced to lead optimization, triggering a EUR500,000 research milestone payment.This partnersh...
15 October 2024 - Clinical-stage biotechnology company Lipella Pharmaceuticals Inc (Nasdaq:LIPO) on Tuesday announced the receipt of a US patent for its proprietary liposomal drug delivery platform.The new patent covers key innovations in the company...
15 October 2024 - Clinical-stage biopharmaceutical company Adocia (Euronext Paris:ADOC) announced on Tuesday that it has filed patent applications for stable combinations of GLP-1 and amylin analogs for the treatment of obesity and diabetes using its...
15 October 2024 - US-based clinical-stage biotechnology company SystImmune, Inc announced on Monday that it has received US Food and Drug Administration clearance for its Investigational New Drug application for BL-M11D1, an antibody-drug conjugate t...
15 October 2024 - Pharmaceutical company Accord BioPharma, Inc., the US division of Intas Pharmaceuticals, announced on Monday that it has received US FDA approval for IMULDOSA (ustekinumab-srlf), a biosimilar to STELARA.IMULDOSA is approved to treat...